Skip to main content
. Author manuscript; available in PMC: 2015 Jul 15.
Published in final edited form as: Biopharm Drug Dispos. 2012 Sep 4;33(7):378–402. doi: 10.1002/bdd.1803

Table 6.

Estimated ranges of the average absorption rate coefficient in vivo (ka) and the average partitioning rate coefficient in vitro (kp) for BCS II compounds based on ranges for surface area to volume ratio in vivo (A/V) and in vitro (AI/Va), and average permeation rate in vivo (Peff) and in vitro (PI)

A/V a Peff × 104b ka × 104c A I /V a d PI × 104e kp × 104f
cm−1 cm/s s−1 cm−1 cm/s s−1
2
(1 to 7)
1 to 14 2 to 28
(1 to 100)
0.16 to 0.47 0.01 to 100 0.002 to 50
a

Estimated based on an A/V of 2 and plausible percent compression based on Table 2.

b

Approximate range for measured human jejunal effective permeation rate for BCS II compounds from reference [32].

c

Calculated – equal to A/V* Peff × 104.

d

Range from Table 1 assuming standard USP guidelines for impeller positioning.

e

Estimated using equation 28 assuming ha from 10 to 50 μm and Da from 10−5 to 10−7cm2/s.

f

Calculated – equal to AI/Va* PI × 104.